Treatment for multiple periorbital eccrine hidrocystomas: Botulinum toxin A

Heather Woolery-Lloyd, Vidya Rajpara, Rajiv I. Nijhawan

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Hidrocystomas are relatively common cystic lesions that can display either apocrine or eccrine differentiation. While numerous treatment modalities exist for solitary hidrocystomas including simple excision, electrodesiccation, and CO2 laser, treatment of multiple hidrocystomas can be challenging. A 38-year-old, black female with a 23-year history of multiple periorbital cystic nodules presented to the clinic with the complaint of lesions that were increasing in size and number. Prior treatment included excision resulting in scarring without signifi cant clinical improvement. Initially, incision and drainage was performed with fl attening of the cysts; however, the cystic nodules refi lled to baseline by 6 weeks. Subsequently, intralesional botulinum toxin type A was offered as an alternate therapy in conjunction with incision and drainage. The patient reported sustained fl attening of the lesions at both 1-month and 4-month follow-up appointments. Intralesional botulinum toxin A offers a novel treatment for patients with multiple hidrocystomas that have failed other therapies.

Original languageEnglish (US)
Pages (from-to)71-73
Number of pages3
JournalJournal of Drugs in Dermatology
Volume8
Issue number1
StatePublished - Jan 2009

Fingerprint

Hidrocystoma
Type A Botulinum Toxins
Drainage
Therapeutics
Gas Lasers
Cicatrix
Cysts
Appointments and Schedules

ASJC Scopus subject areas

  • Dermatology
  • Medicine(all)

Cite this

Treatment for multiple periorbital eccrine hidrocystomas : Botulinum toxin A. / Woolery-Lloyd, Heather; Rajpara, Vidya; Nijhawan, Rajiv I.

In: Journal of Drugs in Dermatology, Vol. 8, No. 1, 01.2009, p. 71-73.

Research output: Contribution to journalArticle

@article{7ec62b37d462489c91dc791980679cae,
title = "Treatment for multiple periorbital eccrine hidrocystomas: Botulinum toxin A",
abstract = "Hidrocystomas are relatively common cystic lesions that can display either apocrine or eccrine differentiation. While numerous treatment modalities exist for solitary hidrocystomas including simple excision, electrodesiccation, and CO2 laser, treatment of multiple hidrocystomas can be challenging. A 38-year-old, black female with a 23-year history of multiple periorbital cystic nodules presented to the clinic with the complaint of lesions that were increasing in size and number. Prior treatment included excision resulting in scarring without signifi cant clinical improvement. Initially, incision and drainage was performed with fl attening of the cysts; however, the cystic nodules refi lled to baseline by 6 weeks. Subsequently, intralesional botulinum toxin type A was offered as an alternate therapy in conjunction with incision and drainage. The patient reported sustained fl attening of the lesions at both 1-month and 4-month follow-up appointments. Intralesional botulinum toxin A offers a novel treatment for patients with multiple hidrocystomas that have failed other therapies.",
author = "Heather Woolery-Lloyd and Vidya Rajpara and Nijhawan, {Rajiv I.}",
year = "2009",
month = "1",
language = "English (US)",
volume = "8",
pages = "71--73",
journal = "Journal of Drugs in Dermatology",
issn = "1545-9616",
publisher = "Journal of Drugs in Dermatology",
number = "1",

}

TY - JOUR

T1 - Treatment for multiple periorbital eccrine hidrocystomas

T2 - Botulinum toxin A

AU - Woolery-Lloyd, Heather

AU - Rajpara, Vidya

AU - Nijhawan, Rajiv I.

PY - 2009/1

Y1 - 2009/1

N2 - Hidrocystomas are relatively common cystic lesions that can display either apocrine or eccrine differentiation. While numerous treatment modalities exist for solitary hidrocystomas including simple excision, electrodesiccation, and CO2 laser, treatment of multiple hidrocystomas can be challenging. A 38-year-old, black female with a 23-year history of multiple periorbital cystic nodules presented to the clinic with the complaint of lesions that were increasing in size and number. Prior treatment included excision resulting in scarring without signifi cant clinical improvement. Initially, incision and drainage was performed with fl attening of the cysts; however, the cystic nodules refi lled to baseline by 6 weeks. Subsequently, intralesional botulinum toxin type A was offered as an alternate therapy in conjunction with incision and drainage. The patient reported sustained fl attening of the lesions at both 1-month and 4-month follow-up appointments. Intralesional botulinum toxin A offers a novel treatment for patients with multiple hidrocystomas that have failed other therapies.

AB - Hidrocystomas are relatively common cystic lesions that can display either apocrine or eccrine differentiation. While numerous treatment modalities exist for solitary hidrocystomas including simple excision, electrodesiccation, and CO2 laser, treatment of multiple hidrocystomas can be challenging. A 38-year-old, black female with a 23-year history of multiple periorbital cystic nodules presented to the clinic with the complaint of lesions that were increasing in size and number. Prior treatment included excision resulting in scarring without signifi cant clinical improvement. Initially, incision and drainage was performed with fl attening of the cysts; however, the cystic nodules refi lled to baseline by 6 weeks. Subsequently, intralesional botulinum toxin type A was offered as an alternate therapy in conjunction with incision and drainage. The patient reported sustained fl attening of the lesions at both 1-month and 4-month follow-up appointments. Intralesional botulinum toxin A offers a novel treatment for patients with multiple hidrocystomas that have failed other therapies.

UR - http://www.scopus.com/inward/record.url?scp=60849099621&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=60849099621&partnerID=8YFLogxK

M3 - Article

C2 - 19180900

AN - SCOPUS:60849099621

VL - 8

SP - 71

EP - 73

JO - Journal of Drugs in Dermatology

JF - Journal of Drugs in Dermatology

SN - 1545-9616

IS - 1

ER -